EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Hepatocyte‐Specific GSDMD Deficiency Aggravates Sepsis by Disrupting Non‐Canonical Secretion of Anti‐Inflammatory Factors

Yihan Qian, Bingrui Wang, Chang Yu, Yuge Zhou, Weifan Huang, Xing Rong, Yali Sang, Jiangang Song, Hailong Wu, Xiaoni Kong iD

Advanced Science · 2025-11 · 12 (43)

DOI: 10.1002/advs.202510412 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Advanced Science, online erschienen am 26.08.2025. Verfasst von Yihan Qian und 9 weiteren Autor:innen. Beteiligte Einrichtung: Central Laboratory, Shuguang Hospital Affiliated to Shanghai University of Traditional Chinese Medicine, Shanghai, 201203, China. Hauptthemen laut MEDLINE: Sepsis, Hepatocytes, Phosphate-Binding Proteins, Intracellular Signaling Peptides and Proteins. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 51 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Shanghai Oriental Talents Leading Project, Shanghai Frontiers Science Center of Disease and Syndrome Biology of Inflammatory Cancer Transformation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Gasdermin D (GSDMD)‐mediated pyroptosis in macrophages plays a clear role in promoting inflammation and mortality in sepsis. The liver is a commonly damaged organ during sepsis and also an important organ for releasing acute response proteins. However, whether pyroptosis occurs and the function of GSDMD in hepatocytes remains unclear. It is surprising to find that hepatocyte‐specific GSDMD knockout (GSDMD hep‐/‐ ) mice have significantly reduced survival rates, markedly elevated systemic inflammation, and increased inflammation in the peritoneal cavity and lungs, suggesting that the absence of GSDMD in hepatocytes promotes systemic inflammatory responses. Serum proteomic analysis shows that anti‐inflammatory factors such as VEGF‐B and Gremlin‐1 are significantly reduced in GSDMD hep‐/‐ mice. Through in vitro and in vivo experiments combined with a constructed full‐length GSDMD and a mutant GSDMD plasmid (GSDMD‐c.D276A) that cannot be cleaved, VEGF‐B and Gremlin‐1 are verified to be released from hepatocytes through the pore‐forming activity of GSDMD, thus inhibiting the production of inflammatory factors by macrophages. More importantly, hepatocyte‐specific replenishment of full‐length GSDMD can reverse the exacerbated inflammatory response in GSDMD hep‐/‐ mice. These findings together establish that hepatic GSDMD plays a key protective role in sepsis by promoting the release of anti‐inflammatory factors through pore formation in hepatocytes.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

SepsisHepatocytesPhosphate-Binding ProteinsIntracellular Signaling Peptides and ProteinsAnti-Inflammatory AgentsAnimalsMiceMice, KnockoutMice, Inbred C57BLPyroptosisInflammationDisease Models, AnimalMaleGasdermins

Stichwörter der Autor:innen

anti‐inflammatory factorsgasdermin Dhepatocytemacrophagesepsis

Substanzen

Phosphate-Binding ProteinsGsdmd protein, mouseIntracellular Signaling Peptides and ProteinsAnti-Inflammatory AgentsGasdermins

Autor:innen und Institutionen

  • Central Laboratory, Shuguang Hospital Affiliated to Shanghai University of Traditional Chinese Medicine, Shanghai, 201203, China.
  • KELUN-BIOTECH, Shanghai, 200023, China.
  • Department of anaesthesiology, Shuguang Hospital Affiliated to Shanghai University of Traditional Chinese Medicine, Shanghai, 201203, China.
  • Shanghai Key Laboratory of Molecular Imaging, Collaborative Innovation Center for Biomedicines, Shanghai University of Medicine and Health Sciences, Shanghai, 201318, China.

ORCID-Profile: Xiaoni Kong

Förderung

  • National Natural Science Foundation of China
  • Shanghai Oriental Talents Leading Project
  • Shanghai Frontiers Science Center of Disease and Syndrome Biology of Inflammatory Cancer Transformation

Zitieren

APA

Qian, Y., Wang, B., Yu, C., Zhou, Y., Huang, W., Rong, X., Sang, Y., Song, J., Wu, H., & Kong, X. (2025). Hepatocyte‐Specific GSDMD Deficiency Aggravates Sepsis by Disrupting Non‐Canonical Secretion of Anti‐Inflammatory Factors. Advanced Science, 12(43). https://doi.org/10.1002/advs.202510412

Vancouver

Qian Y, Wang B, Yu C, Zhou Y, Huang W, Rong X, et al. Hepatocyte‐Specific GSDMD Deficiency Aggravates Sepsis by Disrupting Non‐Canonical Secretion of Anti‐Inflammatory Factors. Advanced Science. 2025;12(43). doi:10.1002/advs.202510412

BibTeX
@article{Qian2025,
  author = {Qian, Yihan and Wang, Bingrui and Yu, Chang and Zhou, Yuge and Huang, Weifan and Rong, Xing and Sang, Yali and Song, Jiangang and Wu, Hailong and Kong, Xiaoni},
  title = {Hepatocyte‐Specific GSDMD Deficiency Aggravates Sepsis by Disrupting Non‐Canonical Secretion of Anti‐Inflammatory Factors},
  journal = {Advanced Science},
  year = {2025},
  volume = {12},
  number = {43},
  doi = {10.1002/advs.202510412}
}
Kostenlos starten →